Active Shortage

APO-GABAPENTIN

APOTEX INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of APO-GABAPENTIN in Canada?

Yes. APO-GABAPENTIN 300MG has an active shortage reported to Health Canada (last updated November 5, 2026).

Why is APO-GABAPENTIN not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will APO-GABAPENTIN be available again?

The manufacturer's estimated resolution date is December 4, 2026. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusActive Shortage

Same-ingredient products on file5 products

Expected resolution~22 days remaining (estimate)

Affected strength300MG

Report last updated2026-11-05

Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

PRO-GABAPENTIN

PRO DOC LIMITEE

300MG · DIN 02310457

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

Other Products

TEVA-GABAPENTIN

TEVA CANADA LIMITED

400MG · DIN 02244515

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

GABAPENTIN

SIVEM PHARMACEUTICALS ULC

100MG · DIN 02246314

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

PMS-GABAPENTIN

PHARMASCIENCE INC

400MG · DIN 02243448

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

RIVA-GABAPENTIN

LABORATOIRE RIVA INC.

400MG · DIN 02251183

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02244305

Strength

300MG

Dosage Form

CAPSULE

Route

ORAL

Active Ingredient

GABAPENTIN

See all GABAPENTIN products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History

2026-11-05

Active Shortage

Disruption of the manufacture of the drug.

2026-09-08

Resolved

Disruption of the manufacture of the drug.

Other Products from APOTEX INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

24HR NASAL ALLERGY RELIEF

50MCG · DIN 02460513

ACETAMINOPHEN CAPLETS 325 MG

325MG · DIN 02362341

ACETAMINOPHEN CAPLETS 500 MG

500MG · DIN 02362368

ACETAMINOPHEN HEADACHE ULTRA RELIEF

DIN 02290901

ACETAMINOPHEN TABLETS USP 325 MG

325MG · DIN 02362422

ACETAMINOPHEN TABLETS USP 500 MG

500MG · DIN 02362244